Focus on elimination of senescent cancer cells. Researchers at the Netherlands Cancer Institute just reported in PNAS that SLC25A23 (involved in mitochondrial transmembrane transport) is a
Science’s 2024 “Breakthrough of the Year” is Gilead’s drug Lenacapavir, an injectable drug that demonstrated remarkable success at preventing HIV infection with one shot every 6
Focus on Drug Approvals. This week the FDA approved Ensartinib for ALK-positive locally advanced or metastatic non-small cell lung cancer. Ensartinib is a potent and specific
Focus on Drug Approvals. The FDA has approved Syndax Pharmaceuticals’ Revumenib (SNDX-5613, inhibitor of menin-KMT2A interaction) for relapsed or refractory acute leukemia with lysine methyltransferase 2A
Is coffee good for your brain? N-Eicosanoyl-serotonin (EHT), a novel natural product found in coffee, has been shown to have a protective effect in models of
Focus on Drug Discovery. A biopharmaceutical company called Soligenix is developing the natural product hypericin as a treatment for cutaneous T-cell lymphoma. Hypericin, applied as a
Website Created by Advanta Advertising LLC.
